These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7283224)

  • 41. [Experience in using the sympatholytic, ornid, in functional obstruction of the intestines in diffuse peritonitis].
    Nechitaĭlo PE
    Klin Khir (1962); 1980 Jan; (1):25-7. PubMed ID: 7374029
    [No Abstract]   [Full Text] [Related]  

  • 42. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Porcine malignant hyperthermia. VI: the effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response.
    Lucke JN; Denny H; Hall GM; Lovell R; Lister D
    Br J Anaesth; 1978 Mar; 50(3):241-6. PubMed ID: 637997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system.
    Olson DW; Thompson BM; Darin JC; Milbrath MH
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):807-10. PubMed ID: 6383135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of bretylium tosylate as prophylaxis and treatment in hypothermic ventricular fibrillation in the canine model.
    Murphy K; Nowak RM; Tomlanovich MC
    Ann Emerg Med; 1986 Oct; 15(10):1160-6. PubMed ID: 3752646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifibrillatory drugs: the case for bretylium tosylate.
    Dronen SC
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):805-7. PubMed ID: 6476547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 51. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous bretylium overdose.
    Gibson JS; Munter DW
    Am J Emerg Med; 1995 Mar; 13(2):177-9. PubMed ID: 7893304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
    Kron IL; Nolan SP
    Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of acetylcholinesterase with a bretylium tosylate photoaffinity probe.
    Branchini BR; Lajiness EJ
    Biochim Biophys Acta; 1986 Oct; 884(1):135-41. PubMed ID: 3768408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of bretylium tosylate on the intraocular pressure of the rabbit.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bretylium tosylate and electrically induced cardiac arrhythmias during hypothermia in dogs.
    Orts A; Alcaraz C; Delaney KA; Goldfrank LR; Turndorf H; Puig MM
    Am J Emerg Med; 1992 Jul; 10(4):311-6. PubMed ID: 1616517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.
    Anderson JL; Popat KD; Pitt B
    Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral and intravenous bretylium disposition.
    Anderson JL; Patterson E; Wagner JG; Stewart JR; Behm HL; Lucchesi BR
    Clin Pharmacol Ther; 1980 Oct; 28(4):468-78. PubMed ID: 7408407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.